[1] |
Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis⁃like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis[J]. Clin Rheumatol, 2009,28(8):979⁃984. doi: 10.1007/s10067⁃009⁃1152⁃9.
|
[2] |
Mainetti C, Terziroli BB, Selmi C. Cutaneous manifestations of dermatomyositis: a comprehensive review[J]. Clin Rev Allergy Immunol, 2017,53(3):337⁃356. doi: 10.1007/s12016⁃017⁃8652⁃1.
|
[3] |
Zampieri S, Valente M, Adami N, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link[J]. Autoimmun Rev, 2010,9(6):449⁃453. doi: 10.1016/j.autrev.2009. 12.005.
|
[4] |
Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria[J]. Rheum Dis Clin North Am, 2002,28(4):723⁃741.
|
[5] |
Leatham H, Schadt C, Chisolm S, et al. Evidence supports blind screening for internal malignancy in dermatomyositis: data from 2 large US dermatology cohorts[J]. Medicine (Baltimore), 2018,97(2):e9639. doi: 10.1097/MD.0000000000009639.
|
[6] |
Bogdanov I, Kazandjieva J, Darlenski R, et al. Dermatomyositis: current concepts[J]. Clin Dermatol, 2018,36(4):450⁃458. doi: 10.1016/j.clindermatol.2018.04.003.
|
[7] |
Gofrit SG, Yonath H, Lidar M, et al. The clinical phenotype of patients positive for antibodies to myositis and myositis⁃related disorders[J]. Clin Rheumatol, 2018,37(5):1257⁃1263. doi: 10. 1007/s10067⁃018⁃4032⁃3.
|
[8] |
Hida A, Yamashita T, Hosono Y, et al. Anti⁃TIF1⁃γ antibody and cancer⁃associated myositis: a clinicohistopathologic study[J].Neurology, 2016,87(3):299⁃308. doi: 10.1212/WNL.0000000000 002863.
|
[9] |
Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal⁃recognition particle[J]. Proc Natl Acad Sci U S A, 1986,83(24):9507⁃9511. doi: 10.1073/pnas.83.24.9507.
|
[10] |
Miller T, Al⁃Lozi MT, Lopate G, et al. Myopathy with antibodies to the signal recognition particle: clinical and pathological features[J]. J Neurol Neurosurg Psychiatry, 2002,73(4):420⁃428. doi: 10.1136/jnnp.73.4.420.
|
[11] |
Hengstman GJ, Vogels OJ, ter Laak HJ, et al. Myositis during long⁃term interferon⁃alpha treatment[J]. Neurology, 2000,54(11):2186.
|
[12] |
Bronner IM, Hoogendijk JE, Wintzen AR, et al. Necrotising myopathy, an unusual presentation of a steroid⁃responsive myopathy[J]. J Neurol, 2003,250(4):480⁃485. doi: 10.1007/s00415⁃003⁃1027⁃y.
|
[13] |
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975,292(7):344⁃347. doi: 10. 1056/NEJM197502132920706.
|
[14] |
Sontheimer RD, Miyagawa S. Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis[J]. J Am Acad Dermatol, 2003,48(5):797⁃798. doi: 10.1067/mjd. 2003.199.
|
[15] |
Yassaee M, Fiorentino D, Okawa J, et al. Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument[J]. Br J Dermatol, 2010,162(3):669⁃673. doi: 10.1111/j.1365⁃2133.2009.09521.x.
|
[16] |
陈梦雅, 郑捷, 曹华. 皮肌炎皮损评分方法的临床应用[J]. 中华皮肤科杂志, 2017,50(1):70⁃72. doi: 10.3760/cma.j.issn.0412⁃4030.2017.01.026.
|
[17] |
Hengstman GJ, ter Laak HJ, Vree Egberts WT, et al. Anti⁃signal recognition particle autoantibodies: marker of a necrotising myopathy[J]. Ann Rheum Dis, 2006,65(12):1635⁃1638. doi: 10.1136/ard.2006. 052191.
|
[18] |
Dimitri D, Andre C, Roucoules J, et al. Myopathy associated with anti⁃signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology[J]. Muscle Nerve, 2007,35(3):389⁃395. doi: 10.1002/mus.20693.
|
[19] |
Kao AH, Lacomis D, Lucas M, et al. Anti⁃signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy[J]. Arthritis Rheum, 2004,50(1):209⁃215. doi: 10.1002/art.11484.
|
[20] |
Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis⁃specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross⁃sectional study[J]. Arch Dermatol, 2011,147(4):391⁃398. doi: 10.1001/archdermatol.2011.52.
|
[21] |
Targoff IN. Update on myositis⁃specific and myositis⁃associated autoantibodies[J]. Curr Opin Rheumatol, 2000,12(6):475⁃481.
|
[22] |
Christopher⁃Stine L, Casciola⁃Rosen LA, Hong G, et al. A novel autoantibody recognizing 200⁃kd and 100⁃kd proteins is associated with an immune⁃mediated necrotizing myopathy[J]. Arthritis Rheum, 2010,62(9):2757⁃2766. doi: 10.1002/art.27572.
|
[23] |
Arouche⁃Delaperche L, Allenbach Y, Amelin D, et al. Pathogenic role of anti⁃signal recognition protein and anti⁃3⁃hydroxy⁃3⁃methylglutaryl⁃CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies[J]. Ann Neurol, 2017,81(4):538⁃548. doi: 10.1002/ana.24902.
|
[24] |
Garcia B, Dabouz F, Pascal L, et al. Amyopathic dermatomyositis (DM) with anti⁃MDA5 antibodies, associated with bullous pemphigoid, Sjögren syndrome and gastric MALT lymphoma[J]. Ann Dermatol Venereol, 2017,144(10):629⁃633. doi: 10.1016/j.annder.2017.05.009.
|
[25] |
Suzuki S, Nishikawa A, Kuwana M, et al. Inflammatory myopathy with anti⁃signal recognition particle antibodies: case series of 100 patients[J]. Orphanet J Rare Dis, 2015,10:61. doi: 10.1186/s13023⁃015⁃0277⁃y.
|
[26] |
Ellis E, Ann TJ, Lester S, et al. Necrotizing myopathy: clinicoserologic associations[J]. Muscle Nerve, 2012,45(2):189⁃194. doi: 10.1002/mus.22279.
|
[27] |
Inoue S, Okiyama N, Shobo M, et al. Diffuse erythema with ′angel wings′ sign in Japanese patients with anti⁃small ubiquitin⁃like modifier activating enzyme antibody⁃associated dermatomyositis[J]. Br J Dermatol, 2018,179(6):1414⁃1415. doi: 10.1111/bjd.17026.
|
[28] |
Pinal⁃Fernandez I, Casal⁃Dominguez M, Carrino JA, et al. Thigh muscle MRI in immune⁃mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti⁃SRP autoantibodies as a marker of severity[J]. Ann Rheum Dis, 2017,76(4):681⁃687. doi: 10.1136/annrheumdis⁃2016⁃210198.
|
[29] |
Tanino Y. Interstitial lung disease is a possible manifestation of anti⁃signal recognition particle antibody syndrome[J]. Intern Med, 2018,57(14):1957⁃1958. doi: 10.2169/internalmedicine. 0662⁃17.
|
[30] |
Römisch K, Miller FW, Dobberstein B, et al. Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages[J]. Arthritis Res Ther, 2006,8(2):R39. doi: 10.1186/ar1895.
|